Adapting wellbeing research tools for Aboriginal and Torres Strait Islander people with chronic kidney disease.
Australia
/ epidemiology
Behavioral Research
/ methods
Comorbidity
Culturally Competent Care
/ methods
Depression
/ diagnosis
Female
Humans
Male
Mental Disorders
/ diagnosis
Mental Health
Middle Aged
Native Hawaiian or Other Pacific Islander
/ psychology
Outcome Assessment, Health Care
/ methods
Pilot Projects
Psychosocial Intervention
/ methods
Renal Dialysis
/ methods
Renal Insufficiency, Chronic
/ ethnology
Surveys and Questionnaires
Telemedicine
/ methods
Chronic kidney disease
E-mental health
Indigenous wellbeing
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
15 04 2020
15 04 2020
Historique:
received:
05
09
2019
accepted:
20
03
2020
entrez:
16
4
2020
pubmed:
16
4
2020
medline:
4
9
2021
Statut:
epublish
Résumé
Chronic kidney disease is an increasingly common health problem for Aboriginal and Torres Strait Islander people. It is associated with multiple concurrent psychosocial stressors frequently resulting in negative impacts on emotional and social wellbeing. There is need for well-designed intervention studies to provide evidence of effective treatment for comorbid depression or other mental illness in this setting. Attention to early phase piloting and development work is recommended when testing complex interventions. This paper documents feasibility testing and adaptation of an existing culturally responsive brief wellbeing intervention, the Stay Strong App, and three commonly used wellbeing outcome measures, in preparation for a clinical trial testing effectiveness of the intervention. The Stay Strong App, which has not been used in the setting of Chronic Kidney Disease before, is reviewed and adapted for people with comorbid wellbeing concerns through expert consensus between research team and an Expert Panel. The outcome measures (Kessler 10, Patient Health Questionnaire 9, and EuroQoL) are valid, reliable, and commonly used tools to assess various aspects of wellbeing, which have also not been used in this context before. Feasibility and acceptability are examined and developed through 3 stages: Pilot testing in a purposive sample of five haemodialysis patients and carers; translation of outcome measures through collaboration between the Aboriginal Interpreter Service, Aboriginal and Torres Strait Islander research officers and the research team; and conversion of translated outcome measures to electronic format. Research team and expert panel consensus led to adaptation of the Stay Strong App for renal patients through selective revision of words and images. Pilot testing identified challenges in delivery of the wellbeing measures leading to word changes and additional prompts, integration of audio translations in 11 local Indigenous languages within an interactive Outcome Measures App, and related research protocol changes. Modelling the complex intervention prior to full-scale testing provided important information about the design of both the outcome measures and the intervention. These changes are likely to better support success in conduct of the clinical trial and future implementation of the intervention in clinical settings.
Sections du résumé
BACKGROUND
Chronic kidney disease is an increasingly common health problem for Aboriginal and Torres Strait Islander people. It is associated with multiple concurrent psychosocial stressors frequently resulting in negative impacts on emotional and social wellbeing. There is need for well-designed intervention studies to provide evidence of effective treatment for comorbid depression or other mental illness in this setting. Attention to early phase piloting and development work is recommended when testing complex interventions. This paper documents feasibility testing and adaptation of an existing culturally responsive brief wellbeing intervention, the Stay Strong App, and three commonly used wellbeing outcome measures, in preparation for a clinical trial testing effectiveness of the intervention.
METHODS
The Stay Strong App, which has not been used in the setting of Chronic Kidney Disease before, is reviewed and adapted for people with comorbid wellbeing concerns through expert consensus between research team and an Expert Panel. The outcome measures (Kessler 10, Patient Health Questionnaire 9, and EuroQoL) are valid, reliable, and commonly used tools to assess various aspects of wellbeing, which have also not been used in this context before. Feasibility and acceptability are examined and developed through 3 stages: Pilot testing in a purposive sample of five haemodialysis patients and carers; translation of outcome measures through collaboration between the Aboriginal Interpreter Service, Aboriginal and Torres Strait Islander research officers and the research team; and conversion of translated outcome measures to electronic format.
RESULTS
Research team and expert panel consensus led to adaptation of the Stay Strong App for renal patients through selective revision of words and images. Pilot testing identified challenges in delivery of the wellbeing measures leading to word changes and additional prompts, integration of audio translations in 11 local Indigenous languages within an interactive Outcome Measures App, and related research protocol changes.
CONCLUSION
Modelling the complex intervention prior to full-scale testing provided important information about the design of both the outcome measures and the intervention. These changes are likely to better support success in conduct of the clinical trial and future implementation of the intervention in clinical settings.
Identifiants
pubmed: 32293331
doi: 10.1186/s12882-020-01776-y
pii: 10.1186/s12882-020-01776-y
pmc: PMC7161120
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
130Subventions
Organisme : National Medical Health and Research Councli
ID : GNT# 1098311
Pays : International
Organisme : National Health and Medical Research Council
ID : NHMRC Fellowship GNT# 1092576
Pays : International
Références
BMC Psychiatry. 2013 Oct 20;13:271
pubmed: 24139186
BMC Nephrol. 2012 Sep 20;13:114
pubmed: 22992225
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Aust Health Rev. 2020 Apr;44(2):234-240
pubmed: 30995950
Aust N Z J Public Health. 2008 Aug;32(4):317-21
pubmed: 18782392
Ann Med. 2001 Jul;33(5):337-43
pubmed: 11491192
Clin J Am Soc Nephrol. 2006 May;1(3):349-52
pubmed: 17699229
Aust N Z J Public Health. 2007 Jun;31(3):259-63
pubmed: 17679245
Kidney Int. 2013 Jul;84(1):179-91
pubmed: 23486521
Semin Dial. 2005 Mar-Apr;18(2):98-102
pubmed: 15771652
Appl Health Econ Health Policy. 2017 Apr;15(2):127-137
pubmed: 28194657
BMJ. 2000 Sep 16;321(7262):694-6
pubmed: 10987780
Aust J Rural Health. 2009 Aug;17(4):174-82
pubmed: 19664081
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Blood Purif. 2016;41(1-3):218-24
pubmed: 26766028
Nephrology (Carlton). 2018 Feb;23 Suppl 1:5-13
pubmed: 29436104